MDS Pharma Services provides preclinical and non-clinical safety evaluation services, and access to a wealth of knowledge applied intelligently to the design and conduct of toxicology, genetic toxicology and safety pharmacology studies.
Our comprehensive panel of drug safety assessment services, extensive experience in supporting drug development from preclinical development through NDA filing, recently expanded AAALAC-accredited facility in Lyon, France, and commitment to on-time delivery of results enable MDS Pharma Services to deliver superior value to pharmaceutical and biotechnology companies.
Core Strengths:
- Commitment to superior client service
- Rapid turnaround time for results
- Client-focused staff with relevant scientific and regulatory experience
- Ability to offer continuous infusion studies
- Access to scientific expertise
- State-of-the-art, AAALAC-accredited facilities
Comprehensive services:
- General toxicology – single dose to carcinogenicity
- Reproductive / developmental toxicology
- Core battery of safety pharmacology and supplemental studies
- Immunotoxicology
- Genetic toxicology – GLP and screening
For more information on study design, pricing, contract and turnaround contact your MDS Pharma Services representative.
